After six months of once- or twice-daily treatment, patients had, on average, 30 to 33 more hairs per square centimeter of scalp, with new growth observed as early as two months
She also laments the current limited access to these medications in Brazil, noting that, From a clinical standpoint, broader affordability would represent a major step forward in expanding access to evidence-based obesity and diabetes treatments. For now, she says the message for clinicians is clear: GLP-1RAs are an effective option for managing weight gain and metabolic complications in patients with psychiatric disorders without serious adverse events
For example, Mounjaro contains the active ingredient tirzepatide, a dual agonist that acts on GLP-1 and GIP
It is categorized into alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD)
Liposoluble vitamins A and E in kidney disease
Pain 123 (3), 294305